Copolymers of hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA) were prepared and used to fabricate a membrane-controlled reservoir-type controlled-release delivery system for chlorhexidine that should be suitable for intra-oral use. The reservoir of the system was prepared bys softening an 80:20 mixture of chlorhexidine diacetate and 50:50 HEMA:MMA copolymer with methyl ethyl ketone (MEK), and pressing standard amounts of the resulting dough-like mixture into silicone rubber molds. A membrane was applied to the reservoirs by rotating them through a solution of 30:70 HEMA:MMA copolymer in MEK. The finished oval-shaped controlled-release pellets were approximately 4. 7 mm wide, 3.3 mm high, and 7.4 mm long, and contained 45.0 ± 3.7 mg of chlorhexidine diacetate. The mean in vitro release rate of chlorhexidine diacetate from the pellets into 37°C water was 608 ± 55 μg/24 h for days 2 through 11, and 389 ± 50 μg/24 h for days 15 to 30 of the test period. The chlorhexidine released on day 30 was biologically active, as determined by a serial dilution assay against Streptococcus mutans. The extended release of biologically active chlorhexidine at a controlled rate from this system suggests that it is worthy of further evaluation for the intra-oral therapy of chlorhexidine-treatable oral infections in non-compliant and physically or mentally compromised individuals.
Get full access to this article
View all access options for this article.
References
1.
Addy, M. and Handley, R. (1981): The Effects of the Incorporation of Chlorhexidine Acetate on Some Physical Properties of Polymcriscd and Plasticised Acrylics , J Oral Rehabil8:155-163.
2.
Addy, M.; Rawle, L.; Handley, R.; Newman, H.N.; and Coventry, J.F. (1982): The Development and in vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug Delivery, J Periodontol53:693-699.
3.
Baker, R.W. and Lonsdale, H.K. (1974): Controlled Release: Mechanisms and Rates, Adv Exp Med Biol47:15-71.
4.
Bonesvoll, P. and Gjermo, P. (1978): A Comparison Between Chlorhcxidinc and Some Quaternary Ammonium Compounds With Regard to Retention, Salivary Concentrations and Plaquc-inhibiting Effect in the Human Mouth After Mouth Rinses, Arch Oral Biol23:289-294.
5.
Bonesvoll, P.; Lokken, P.; Rolla, G.; and Paus, P.N. (1974): Retention of Chlorhexidine in the Human Oral Cavity After Mouth Rinses, Arch Oral Biol19:209-212.
6.
Bonesvoll, P. and Olsen, I. (1974): Influence of Teeth, Plaque, and Dentures on the Retention of Chlorhexidine in the Human Oral Cavity, J Clin Periodontol1:214-221.
7.
Brougham, L.A.; Cheng, H.; and Pittman, K.A. (1986): Sensitive High-Pcrformance Liquid Chromatographic Method for the Determination of Chlorhexidine in Human Serum and Urine, J Chromatogr383:365-373.
8.
Budtz-Jorgensen, E. (1977): Hibitane in the Treatment of Oral Candidiasis , J Clin Periodontol4:117-128.
9.
Budtz-Jorgensen, E. and Löe, H. (1972): Chlorhexidine as a Denture Disinfectant in the Treatment of Denture Stomatitis, Scand J Dent Res80:457-464.
10.
Chien, Y.W. (1982): Novel Drug Delivery Systems, New York: Marccl Dckker, pp. 1-11.
11.
Cowsar, D.R. (1974): Introduction to Controlled Release, Adv Exp Med Biol47:1-13.
12.
Cowsar, D.R.; Tarwater, O.R.; and Tanquary, A.C. (1976): Controlled Release of Fluoride From Hydrogels for Dcntal Applications, Am Chem Soc Symp Ser31:180-197.
13.
Curran, J.W.; Jaffe, H.W.; Hardy, A.M.; Morgan, W.M.; Selik, R.M.; and Dondero, T.J. (1988): Epidemiology of HIV Infection and AIDS in the United States, Science239 :610-616.
14.
Dixon, W.J. and Massey, F.J., Jr. (1957): Introduction to Statistical Analysis , 2nd ed., New York: McGraw-Hill, pp. 189-199.
15.
Fardal, O. and Turnbull, R.S. (1986): A Review of the Literature on Use of Chlorhcxidinc in Dentistry, J Am Dent Assoc112:863-869.
16.
Ferretti, G.S.; Ash, R.C.; Brown, A.T.; Largent, B.M.; Kaplan, A.; and Lillich, T.T. (1987a): Chlorhexidine for Prophylaxis Against Oral Infections and Associated Complications in Patients Receiving Bone Marrow Transplants , J Am Dent Assoc114:461-467.
17.
Ferretti, G.S.; Hansen, I.A.; Whittenburg, K.; Brown, A.T.; Lillich, T.T.; and Ash, R.C. (1987b): Therapcutic Use of Chlorhcxidinc in Bone Marrow Transplant Patients: Case Studies, Oral Med Oral Surg Oral Pathol63:683-687.
18.
Francis, J.R.; Addy, M.; and Hunter, B. (1987): A Comparison of Three Delivery Methods of Chlorhexidine in Handicapped Children. II. Parent and House-Parent Preferences, J Periodontol58:456-459.
19.
Friedman, M. and Golomb, G. (1982): New Sustained Release Dosage Form of Chlorhexidine for Dental Use. I. Development and Kinetics of Release, J Periodont Res17:323-328.
20.
Friedman, M.; Harari, D.; Raz, H.; Golomb, G.; and Brayer, L. (1985): Plaque Inhibition by Sustained Release of Chlorhcxidine From Removable Appliances, J Dent Res64 :1319-1321.
Gjermo, P.; Bonesvoll, P.; and Rolla, G. (1974): Rclartionship Between Plaque-inhibiting Effect and Retention of Chlorhexidine in the Human Oral Cavity, Arch Oral Biol19:1031-1034.
23.
Good, W.R. and Lee, P.I. (1984): Membrane-controlled Reservoir Drug Delivery Systems . In: Medical Applications of Controlled Release, Vol. 1, Classes of Systems, R.S. Langer and D.L. Wise, Eds., Boca Raton, FL: CRC Press, pp. 1-39.
24.
Ho, D.D.; Pomerantz, R.J.; and Kaplan, J.C. (1987): Pathogenesis of Infection With Human Immunodeficiency Virus, New Engl J Med317:278-286.
25.
Klein, R.S.; Harris, C.A.; Small, C.B.; Moll, B.; Lesser, M.; and Friedland, G.H. (1984): Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency Syndrome, New Engl J Med311 :354-358.
26.
Lamb, D.J. and Martin, M.V. (1983): An in vitro and in vivo Study of the Effect of Incorporation of Chlorhexidine Into Auto-polymerizing Acrylic Resin Plates Upon the Growth of Candida albicans, Biomaterials4:205-209.
27.
Lang, N.P. and Brecx, M.C. (1986): Chlorhexidinc Digluconate-An Agent for Chemical Plaque Control and Prevention of Gingival Inflammation, J Periodont Res (Suppl)16:74-89.
28.
Langslet, A.; Olsen, I.; Lie, S.O.; and Lokken, P. (1974): Chlorhexidine Treatment of Oral Candidiasis in Seriously Diseased Children, Acta Paediatr Scand63:809-811.
29.
Little, W.A.; Thomson, L.A.; and Bowen, W.H. (1979): Antibiotic Susceptibility of Streptococcus mutans: Comparison of Serotypc Profiles, Antimicrob Agents Chemother15:440-443.
30.
McCourtie, J.; MacFarlane, T.W.; and Samaranayake, L.P. (1985): Effect of Chlorhexidine Gluconate on the Adherence of Candida Species to Denture Acrylic, J Med Microbiol20 :97-104.
31.
McGaw, W.T. and Belch, A. (1985): Oral Complications of Acute Leukemia: Prophylactic Impact of a Chlorhexidine Mouth Rinse Regimen, Oral Surg Oral Med Oral Pathol60:275-280.
32.
Mirth, D.B. (1987): Controlled-release Therapeutic Systems: Technology Applicable to the Treatment of Oral Disease, Adv Dent Res1:109-118.
33.
Mirth, D.B.; Bartkiewicz, A.; Little, W.A.; and Shern, R.J. (1986): Intra-oral Controlled-release Delivery System for Tctracycline, J Dent Res65:334, Abst. No. 1488 (AADR).
34.
Olanoff, L. and Anderson, J.M. (1979): Controlled Release of Tctracycline II: Development of an in vivo Flow-limited Pharmacological Model, J Pharm Sci68:1151-1155.
35.
Olanoff, L.; Konis, T.; and Anderson, J.M. (1979): Controlled Release of Tetracycline I : in vitro Studies with a Trilaminatc 2-Hydroxyethyl Mcthacrylate System, J Pharm Sci68 :1147-1150
36.
Olsen, I. (1975a): Denture Stomatitis. Effects of Chlorhexidine and Amphotcricin B on the Mycotic Flora, Acta Odontol Scand33 :41-46.
37.
Olsen, I. (1975b): Denture Stomatitis. The Clinical Effects of Chlorhexidine and Amphotcricin B, Acta Odontol Scand33 :47-52.
38.
Price, R.W.; Brew, B.; Sidits, J.; Rosenblum, M.; Scheck, A.C.; and Cleary, P. (1988): The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia Complex, Science239:586-592.
39.
Rolla, G.; Löe, H.; and Schiott, C.R. (1970): Affinity of Chlorhexidine to Hydroxyapatite and to Salivary Mucins, J Periodont Res5:90-95.
40.
Shaw, J.E. (1980): Drug Delivery Systems, Ann Repts Med Chem15:302-315.
41.
Soskolne, A.; Golomb, G.; Friedman, M.; and Sela, M.N. (1983): New Sustained Release Dosage Form of Chlorhexidine for Dental Use, J Periodont Res18:330-336.
42.
Stabholz, A.; Sela, M.N.; Friedman, M.; Golomb, G.; and Soskolne, A. (1986): Clinical and Microbiological Effects of Sustained Release Chlorhexidine in Periodontal Pockets, J Clin Periodontol13:783-788.
43.
Storhaug, K. (1977): Hibitane in Oral Disease in Handicapped Patients , J Clin Periodontol4:102-107.
